Arkolith/Insider Trading/LVTX/Form 4

Versant Vantage I, L.P.

10% OwnerLAVA Therapeutics NV (LVTX) · full profile →Form 4 · filed Sep 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.1M
Net Open-Market Flow
-$4.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2025Sell(S)2.4M$1.40$3.3M0
Sep 19, 2025Sell(S)533K$1.40$746K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-213445) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML